Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q3

Onco Therapeutics

Begell House Inc.

United StatesBiotechnology (Q3); Biochemistry (Q4); Genetics (Q4); Molecular Medicine (Q4)ISSN-matched source record
Q3Ranking
—Impact Factor (year unverified)
3H-index (SCImago 2025)
0.309SJR (2025)
2021-2022Coverage

About Onco Therapeutics

Onco Therapeutics is a scholarly journal published by Begell House Inc.. SCImago 2025 lists it in Q3, with an SJR of 0.309 and H-index of 3.

Coverage: 2021-2022. Research categories: Biotechnology (Q3); Biochemistry (Q4); Genetics (Q4); Molecular Medicine (Q4).

Source-backed journal facts

ISSN(s)2694-4642, 2694-4650
ISSN-L2694-4642
Source typeJournal
Publisher / hosting organisationBegell House
Publisher country codeUS
Fully open access (OpenAlex)Not marked as fully open access; hybrid options may exist
DOAJ flag (OpenAlex)Not listed in OpenAlex metadata; this is not a direct DOAJ check
Works recorded in OpenAlex30
Citations recorded in OpenAlex51
OpenAlex H-index4
Years represented in OpenAlex2021–2022 (not the founding or closing dates)

Topics in published research

Immune cells in cancer; Curcumin's Biomedical Applications; Phytochemicals and Antioxidant Activities; Cancer Immunotherapy and Biomarkers; Epigenetics and DNA Methylation; Cancer, Hypoxia, and Metabolism.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-09-17. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit